BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32071350)

  • 1. Transfusion Challenges in Patients with Hematological Malignancies in Sub-Saharan Africa: A Prospective Observational Study from the Uganda Cancer Institute.
    Ddungu H; Krantz EM; Kajja I; Naluzze S; Nabbanja H; Nalubwama F; Phipps W; Orem J; Wald A; Kiwanuka N
    Sci Rep; 2020 Feb; 10(1):2825. PubMed ID: 32071350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.
    Ddungu H; Krantz EM; Kajja I; Naluzze S; Nabbanja H; Nalubwama F; Phipps W; Orem J; Kiwanuka N; Wald A
    PLoS One; 2019; 14(2):e0211648. PubMed ID: 30726290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence and Clinical Significance of Preoperative Thrombocytopenia in Adults Undergoing Elective Surgery: An Observational Cohort Study.
    Matzek LJ; Hanson AC; Schulte PJ; Evans KD; Kor DJ; Warner MA
    Anesth Analg; 2021 Mar; 132(3):836-845. PubMed ID: 33433115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions.
    Hume HA; Ddungu H; Angom R; Baluku H; Kajumbula H; Kyeyune-Byabazaire D; Orem J; Ramirez-Arcos S; Tobian AA
    Transfusion; 2016 Aug; 56(8):1951-9. PubMed ID: 27079627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
    Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD
    Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting.
    Ypma PF; Kerkhoffs JL; van Hilten JA; Middelburg RA; Coccoris M; Zwaginga JJ; Beckers EM; Fijnheer R; van der Meer PF; Brand A
    Transfus Med; 2012 Dec; 22(6):426-31. PubMed ID: 23036067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
    Gubanova MN; Ayupova RF; Zhiburt EB
    Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses.
    Anglin CO; Spence JS; Warner MA; Paliotta C; Harper C; Moore C; Sarode R; Madden C; Diaz-Arrastia R
    J Neurosurg; 2013 Mar; 118(3):676-86. PubMed ID: 23259827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia.
    Wallace MJ; Narvios A; Lichtiger B; Ahrar K; Morello FA; Gupta S; Madoff DC; Hicks ME
    J Vasc Interv Radiol; 2003 Mar; 14(3):323-7. PubMed ID: 12631636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
    Stanworth SJ; Dyer C; Casbard A; Murphy MF
    Vox Sang; 2006 Jul; 91(1):63-9. PubMed ID: 16756603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of hematological profiles on the transfusion management and mortality risk of mothers presenting to the obstetric unit of a South African tertiary medical facility.
    Linström M; Musekwa E; Nell EM; de Waard L; Chapanduka Z
    Transfusion; 2024 Jun; 64(6):986-997. PubMed ID: 38661229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Freeze-dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies.
    Ohanian M; Cancelas JA; Davenport R; Pullarkat V; Hervig T; Broome C; Marek K; Kelly M; Gul Z; Rugg N; Nestheide S; Kinne B; Szczepiorkowski Z; Kantarjian H; Pehta J; Biehl R; Yu A; Aung F; Antebi B; Fitzpatrick GM
    Am J Hematol; 2022 Mar; 97(3):256-266. PubMed ID: 34748664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
    Callow CR; Swindell R; Randall W; Chopra R
    Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
    Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental umbilical cord blood transfusion: a new method of treatment of patients with diabetes and microalbuminuria in the background of anemia.
    Bhattacharya N
    Clin Exp Obstet Gynecol; 2006; 33(3):164-8. PubMed ID: 17089581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery.
    Lackritz EM; Hightower AW; Zucker JR; Ruebush TK; Onudi CO; Steketee RW; Were JB; Patrick E; Campbell CC
    AIDS; 1997 Oct; 11(12):1487-94. PubMed ID: 9342071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.